Advances in Imaging Modalities and Contrast Agents for the Early Diagnosis of Colorectal Cancer

J Biomed Nanotechnol. 2021 Apr 1;17(4):558-581. doi: 10.1166/jbn.2021.3064.

Abstract

Colorectal cancer is one of the most common gastrointestinal cancers worldwide. The mortality rate of colorectal cancer has declined by more than 20% due to the rapid development of early diagnostic techniques and effective treatment. At present, there are many diagnostic modalities available for the evaluation of colorectal cancer, such as the carcinoembryonic antigen test, the fecal occult blood test, endoscopy, X-ray barium meal, computed tomography, magnetic resonance imaging, and radionuclide examination. Sensitive and specific imaging modalities have played an increasingly important role in the diagnosis of colorectal cancer following the rapid development of novel contrast agents. This review discusses the applications and challenges of different imaging techniques and contrast agents applied to detect colorectal cancer, for the purpose of the early diagnosis and treatment of patients with colorectal cancer.

Publication types

  • Review

MeSH terms

  • Colorectal Neoplasms* / diagnostic imaging
  • Contrast Media*
  • Early Detection of Cancer
  • Humans
  • Magnetic Resonance Imaging
  • Tomography, X-Ray Computed

Substances

  • Contrast Media